FDA NDC Directory · JSON-LD · Markdown

Survanta

NDC 0074-1040 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Generic nameBeractant
Labeler / ManufacturerAbbVie Inc.
Marketing categoryBiologic License Application · App BLA020032
Dosage form / routeSUSPENSION · ENDOTRACHEAL
Active ingredientsBERACTANT (25 mg/mL)
Marketing started19910701
Package count2

External sources

Source: openFDA. Public-domain (CC0).